HPA for immunohistochemical staining on SLC16A1 protein in testicular cancer (Figure 1D), and prostate (Figure 1E) were found to have a high signal intensity, and this was also the same in Renal cancer (Figure 1F), uroepithelial cancer (Figure 1G). This evidence concerns the gene SLC16A1 and renal carcinoma.